期刊文献+

神经母细胞瘤患儿外周血γδ T细胞比例及凋亡变化特点

The Characteristics of Peripheral Blood γδ T Cell Proportion and Its Apoptosis in Children with Neuroblastoma
下载PDF
导出
摘要 目的分析研究神经母细胞瘤(NB)患儿外周血中γδT细胞比例以及多种细胞因子水平变化情况,并进行γδT细胞的体外培养,分析其凋亡特点,探讨神经母细胞瘤患儿外周血γδT细胞的变化特点及临床意义。方法通过流式细胞术检测NB患儿外周血中γδT细胞(CD3^+、TCRγδ^+)比例,并与健康儿童比较;通过luminex200液相悬浮芯片系统检测细胞因子表达;探索并优化γδT细胞体外培养条件(PAM+IL-2),培养过程中通过检测Annexin V分析细胞凋亡情况。结果 NB患儿外周血中γδT细胞比例明显升高,患者外周血中多种促生存细胞因子减少;同时我们在体外刺激γδT细胞增殖,发现γδT细胞凋亡增加。结论 NB患儿外周血中γδT细胞呈现病理性升高,并且细胞凋亡增加,其可能与外周血中促生存细胞因子减少相关,增加γδT细胞抗凋亡能力,对于其用于NB临床治疗具有重要意义。 Objective The aim of this study is to investigate the proportion of γδ T cells and concentrations of multiple cytokines in peripheral blood of neuroblastoma patients.Furthermore,we will also stimulate γδ T cell proliferation and analyze the apoptosis of γδ T cells.Methods The proportion of peripheral blood γδ T cells(CD3^+、TCRγδ^+)from children with NB was analyzed through flow cytometry.The concentrations of multiple cytokines were detected by luminex200 system.We then stimulated and cultured ,γδ T cells in the condition of PAM and IL-2,and detected the cell apoptosis by Annexin V staining.Results The γδ T cells proportion of NB patients were up-regulated significantly and cytokines with survival promoting effect in serum were down-regulated.Moreover,we found an increase of the apoptosis of NB patient γδ T cells during in vitro culture.Conclusion Our research revealed a pathological augment of γδ T cell proportion and its apoptosis in NB patients,which might due to the decrease of cytokines with survival promoting effect.With that knowledge,we proposed that enhancing the anti-apoptosis ability of γδ T cell is significant to its application to NB clinic treatment.
作者 王晓林 牟雯君 陈曦 张辉 桂晋刚 WANG Xiao-lin;MOU Wen-jun;CHEN Xi;ZHANG Hui;GUI Jin-gang(Laboratory of Immunology,Key Laboratory of Major Disease in Children,Ministry of Education,Beijing Pediatric Reseatch Institute Beijing Children's Hospital,Capital Medical University,National Center for Children s Health.Beijing 100045,China)
出处 《标记免疫分析与临床》 CAS 2018年第11期1730-1735,共6页 Labeled Immunoassays and Clinical Medicine
基金 国家自然科学面上基金项目《Mcl-1介导的γδ T细胞凋亡调控对神经母细胞瘤的杀伤作用研究》(编号:81772668)
关键词 γδ T细胞 神经母细胞瘤 细胞凋亡 细胞因子 流式细胞术 γδ T cells Neuroblatoma Cell apoptosis Cytokines Flow cytometry
  • 相关文献

参考文献1

二级参考文献37

  • 1Peng L, Shu S Krauss JC. Treatment of subcutaneous tumor with adoptively transferred T cells. Cell Immuno11997; 178: 24-32.
  • 2Rosenberg SA, Spiess P, Lafreniere R. A new approach tothe adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 1986; 233: 1318-1321.
  • 3Plautz GE, Bukowski RM, Novick AC, Klein EA, Kursh ED, Olencki TE et al T-cell adoptive immunotherapy of metastatic renal cell carcinoma. Urology1999; 54: 617-623; discussion 623-614.
  • 4Dudley ME, Wunderlich J, Nishimura MI, Yu D, Yang JC, Topalian SL etalAdoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother 2001; 24: 363-373.
  • 5Dudley ME, Rosenberg SA. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat Rev Cancer 2003; 3: 666-675.
  • 6Clay TM, Custer MC, Sachs J, Hwu P, Rosenberg SA, Nishimura MI. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti- tumor reactivity. J Immuno11999; 163: 507-513.
  • 7Morgan RA, Dudley ME, Yu YY, Zheng Z, Robbins PF, Theoret MR etaL High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens. J Immuno12003; 171: 3287-3295.
  • 8Hughes MS, Yu YY, Dudley M E, Zheng Z, Robbins PF, Li Y etal Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions. Hum Gene TheY2005; 16: 457-472.
  • 9Stanislawski T, Voss RH, Lotz C, Sadovnikova E, Willemsen RA, Kuball Jet al. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat Immuno12001; 2: 962-970.
  • 10Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM etal. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006; 314: 126-129.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部